home / stock / ivevf / ivevf news

IVEVF News and Press, Inventiva From 02/10/25

Stock Information
Company Name: Inventiva
Stock Symbol: IVEVF
Market: OTC
Website: inventivapharma.com
Menu
IVEVF IVEVF Quote IVEVF Short IVEVF News IVEVF Articles IVEVF Message Board
Get IVEVF Alerts

News, Short Squeeze, Breakout and More Instantly...
IVEVF - Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update

Revenues of €9.2 million for the full year of 2024 Cash and cash equivalents at €96.6 million as of December 31, 2024 First tranche of up to €348 million structured financing closed with aggregate gross proceeds of €116 million Last patient screened in the ...
IVEVF - Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology

As previously reported 1 , the study met the primary efficacy endpoint for the treatment with lanifibranor 800mg demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy ( 1 H-MRS) following 24 weeks of treatment in patients with MASLD and T2D ...

IVEVF - Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025

Daix (France), New York City (New York, United States), January 22, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the...

Previous 10 Next 10